Hypolipidemic effects of coenzyme Q10 in experimentally induced hypercholesterolemic model in female rats

American Journal of Pharmacology and Toxicology

Volumn 5, Issue 1, 2010, Pages 14-23

  Al Attar, Atef M ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Coenzyme Q10; High cholesterol diet; Lipid profile; Rats

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UBIDECARENONE; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; FEMALE; HYPERCHOLESTEROLEMIA; NONHUMAN; RAT; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT CHANGE;

ANIMALIA; RATTUS; ZEA MAYS;

EID: 77949898324     PISSN: 15574962     EISSN: 15574970     Source Type: Journal    
DOI: 10.3844/ajptsp.2010.14.23     Document Type: Article

References (76)

1. Amin, K.A. and M.A. Nagy, 2009. Effect of Carnitine and herbal mixture extract on obesity induced by high fat diet in rats. Diabetol. Metab. Syndr., 1: 17. http://www.ncbi.nlm.nih.gov/pubmed/19835614
2. Ashakumary, A. and P.L. Vijammal, 1993. Additive effect of alcohol and nicotine on lipid metabolism in rats. Indian J. Exp. Biol., 31: 270-274. http://www.ncbi.nlm.nih.gov/pubmed/8500841
3. Balkan, J., S.D. Ru-Abbasoglu, G. Aykac-Toker and M. Uysal, 2004. The effect of a high cholesterol diet on lipids and oxidative stress in plasma, liver and aorta of rabbits and rats. Nutr. Res., 24: 229-234. DOI: 10.1016/j.nutres.2003.10.005
4. Barbieri, B., B. Lund, B. LundstrÖm and F. Scaglione, 1999. Coenzyme Q10 administration increases antibody titer in hepatitis B vaccinated volunteers - a single blind placebo-controlled and randomized clinical study. Biofactors, 9: 351-317. http://www.ncbi.nlm.nih.gov/pubmed/10416052
5. Beere, P.A., S. Glagov and Ch.K. Zarins, 1992. Experimental atherosclerosis at the carotid bifurcation of the cynomolgus monkey. Arterioscl. Thrombos., 12: 1245-53. http://www.ncbi.nlm.nih.gov/pubmed/1420083
6. Bhalodia, Y.S., N.R. Sheth, J.D. Vaghasiya and N.P. Jivani, 2010. Hyperlipidemia enhanced oxidative stress and inflammatory response evoked by renal ischemia/reperfusion injury. Int. J. Pharmcol., 6: 25-30. DOI: 10.3923/ijp.2010.25.30
7. Bowry, V.W., D. Mohr, J. Cleary and R. Stocker, 1995. Prevention of tocopherol-mediated peroxidation in ubiquinol-10-free human low density lipoprotein. J. Biol. Chem., 270: 5756-5763. http://www.ncbi.nlm.nih.gov/pubmed/ 7890704
8. Butler, M.G., M. Dasouki, D. Bittel, S. Hunter and A. Naini et al., 2003. Coenzyme Q10 levels in Prader-Willi syndrome: Comparison with obese and non-obese subjects. Am. J. Med. Genet. A., 119: 168-171. http://www.ncbi.nlm.nih.gov/pubmed/12749057
9. Chang, W.C., Y.M. Yu, Y.M. Hsu, C.H. Wu and P.L. Yin et al., 2006. Inhibitory effect of Magnolia officinalis and lovastatin on aortic oxidative stress and apoptosis in hyperlipidemic rabbits. J. Cardiovasc. Pharmacol., 47: 463-468. http://www.ncbi.nlm.nih.gov/pubmed/16633091
10. Codoñer-Franch, P., A.B. López-Jaén, P. Muñiz, E. Sentandren and V.V. Bellés, 2008. Mandarin juice improves the antioxidant status of hypercholesterolemic children. J. Pediatr. Gastroenterol. Nutr., 47: 349-355. http://www.ncbi.nlm.nih.gov/pubmed/18728533
11. Combs, A.B., D.T. Faria, S.W. Leslie and H.W. Bonner, 1981. Effect of Coenzyme Q10 on Adriamycin Induced Changes in Myocardial Calcium. In: Biomedical and Clinical Aspects of Coenzyme Q, Folkers, K. and Y. Yamamura (Eds.). Elsevier, Amsterdam, ISBN: 0444415796, pp: 137-144.
12. Cooke, M., M. Iosia, T. Buford, B. Shelmadine and G. Hudson et al., 2008. Effects of acute and 14-day coenzyme Q10 supplementation on exercise performance in both trained and untrained individuals. J. Int. Soc. Sports Nut., 5: 8. http://www.ncbi.nlm.nih.gov/pubmed/18318910
13. Cortes, E.P., G. Mohinderl, M. Pate, A. Mundia and K. Folkers, 1977. Study of Administration of Coenzyme Q10 to Adriamycin Treated Cancer Patients. In: Biomedical and Clinical Aspects of Coenzyme Q, Folkers, K. and Y. Yamamura (Eds.). Elsevier, Amsterdam, ISBN: 0444415796, pp: 267-273.
14. Dietschy, J.M., S.D. Turley and D.K. Spady, 1993. Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species including humans. J. Lipid Res., 34: 1637-1659. http://www.ncbi.nlm.nih.gov/pubmed/8245716
15. Folkers, K., P.H. Langsjoen, Y. Nara, K. Muratsu and J. Komorowski et al., 1988. Biochemical deficiencies of coenzyme Q10 in HIV-infection and the exploratory treatment. Biochem. Biophys. Res. Commun., 153: 888-896. http://www.ncbi.nlm.nih.gov/pubmed/3382410
16. Folkers, K., R. Brown, W.V. Judy and M. Morita, 1993. Survival of cancer patients on therapy with coenzyme Q10. Biochem. Biophys. Res. Commun., 192: 241-245. http://www.ncbi.nlm.nih.gov/pubmed/8476426
17. Greenberg, S. and W.H. Frishman, 1990. Co-enzyme Q10: A new drug for cardiovascular disease. J. Clin. Pharmacol., 30: 596-608. http://www.ncbi.nlm. nih.gov/pubmed/2202752
18. Hansen, I.L., Y. Iwamoto, T. Kishi, K. Folkers and L.E. Thomposon, 1976. Bioenergetics in clinical medicine. IX. Gingival leucocytic deficiencies of coenzyme Q10 in patients with periodontal disease. Res. Commun. Chem. Pathol. Pharmacol., 14: 729-738. http://www.ncbi.nlm.nih.gov/pubmed/959667
19. He, G.W., W.J. Ou, B. Fan, R. Jing and R. He, 2008. The protective effect of Yi-Qi-Yang-Yin-Ye, a compound of traditional Chinese herbal medicine in diet-induced obese rats. Am. J. Chin. Med., 36: 705-717. http://www.ncbi.nlm. nih.gov/pubmed/18711768
20. Hsu, C.L. and G.C. Yen, 2007. Effect of gallic acid on high fat diet-induced dyslipidaemia, hepatosteatosis and oxidative stress in rats. Br. J. Nutr., 98: 727-735. http://www.ncbi.nlm.nih.gov/pubmed/17475086
21. Ingold, K.U., V.W. Bowry, R. Stocker and C. Walling, 1993. Autoxidation of lipids and antioxidation by alpha-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids: Unrecognized consequences of lipid particle size as exemplified by oxidation of human low density lipoprotein. Proc. Natl. Acad. Sci. USA., 90: 45-49. http://www.ncbi.nlm.nih. gov/pubmed/8419943
22. Ito, H., T. Nakajima, R. Takikawa, E. Hamada and M. Iguchi, et al., 1991. Coenzyme Q10 attenuates cyanide-activation of the ATP-sensitive K+ channel current in single cardiac myocytes of the guinea-pig. Naunyn Schmiedebergs Arch. Pharmacol., 344: 133-136. http://www.ncbi.nlm.nih.gov/ pubmed/1775189
23. Iwamoto, Y., T. Watanabe, H. Okamoto, N. Ohata and K. Folkers, 1981. Clinical Effect of Coenzyme Q10 on Periodontal Disease. In: Biomedical and Clinical Aspects of Coenzyme Q10, Folkers, K. and Y. Yamamura (Eds.). Elsevier, Amsterdam, ISBN: 0444415796, pp: 109-119.
24. Jain, G.C. and S. Agarwal, 2006. Favourable effect of Cleome viscosa L. on serum and hepatic lipids in hyperlipidemic rats. Asian J. Exp. Sci., 20: 331-336. ajes.in/PDFs/06-2/16-GC%20JAIN.pdf
25. Jessani, S., T. Watson, F.P. Cappucio and G.Y. Lip, 2006. Prevention of cardiovascular disease in clinical practice, The Joint British Socities'(JBS2) guidelines. J. Hum. Hypertens, 20: 641-645. DOI:10.1038/sj.jhh.1002058
26. Judy, W.V. J.H. H., W. Dugan, P.D. Toth and K. Folkers, 1983. Coenzyme Q10 Reduction of Adriamycin Toxicity. In: Biomedical and Clinical Aspects of Coenzyme Q, Folkers, K. and Y. Yamamura (Eds.). ISBN; 0444603807, pp: 231-241.
27. Kanashiro, A., D.C. Andrade, L.M. Kabeya, W.M. Turato and L.H. Faccioli et al., 2009. Modulatory effects of rutin on biochemical and hematological parameters in hypercholesterolemic golden syrian hamsters. An. Acad. Bras. Cienc., 81: 67-72. http://www.ncbi.nlm.nih.gov/pubmed/19274333
28. Khanna, A., F. Rizion and R. Chada, 2002. Lipid lowering activity of Phyllanthus niruri in hyperlipidemic rats. J. Ethnopharmacol., 82: 19-23. DOI: 10.1016/S0378-8741(02).
29. Kim, M.Y., C.H. Cheong, M.H. Kim, C. Son and H.S. Yook et al., 2009. Leafy vegetable mix supplementation improves lipid profiles and antioxidant status in C57BL/6J mice fed a high fat and high cholesterol diet. J. Med. Food, 12: 877-884. http://www.ncbi.nlm.nih.gov/pubmed/19735190
30. Kmietowicz, Z., 2002. WHO warns of heart disease threat to developing world. BM.J., 325: 853. http://www.ncbi.nlm.nih.gov/pubmed/12386021
31. Koya-Miyata, S., N. Arai, A. Mizote, Y. Taniquchi and S. Ushio et al., 2009. Propolis prevents dietinduced hyperlipidemia and mitigates weight gain in diet-induced obesity in mice. Biol. Pharm. Bull., 32: 2022-2028. http://www.ncbi.nlm.nih.gov/pubmed/19952422
32. Langsjoen, P.H., P.H. Langsjoen, K. Folkers and P. Richardson, 1991. Treatment of Patients with Human Immunodeficiency Virus Infection with Coenzyme Q10. In: Biomedical and Clinical Aspects of Coenzyme Q, Folkers, K., G.P. Littarru and T. Yamagami (Eds.). Elsevier, Amsterdam, ISBN: 0444811524, pp: 409-415.
33. Lawen, A., R.D. Martinus, G. McMullen, P. Nagley and F. Vaillant et al., 1994. The universality of bioenergetic disease: The role of mitochondrial DNA mutation and the putative inter-relationship betweenmitochondria and plasma membrane NADH oxidases. Mol. Aspects Med., 15: S13-S27. http://www.ncbi.nlm.nih.gov/pubmed/7752823
34. Lee, J.H., C.W. Son, M.Y. Kim, H.R. Kim and E.S. Kwak et al., 2009. Red beet (Beta vulgaris L.) leaf supplementation improves antioxidant status in C57BL/6J mice fed high fat high cholesterol diet. Nutr. Res. Pract., 3: 114-121. http://www.ncbi.nlm.nih.gov/pubmed/20016711
35. Linnane, A.W., C. Zhang, A. Baumer and P. Nagley, 1992. Mitochondrial DNA mutation and the aging process: Bioenergy and pharmacological intervention. Mut. Res., 275: 195-208. http://www.ncbi.nlm.nih.gov/pubmed/1383761
36. Linnane, A.W., G. Kopsidas, C. Zhang, N. Yarovaya and S. Kovalenko et al., 2002. Cellular redox activity of coenzyme Q10: Effect of CoQ10 supplementation on human skeletal muscle. Free Radic. Res., 36: 445-453. http://www.ncbi.nlm.nih.gov/pubmed/12069109
37. Littarru, G.P., S. Lippa, A. Oradei, R.M. Fiorni and L. Mazzanti, 1991. Metabolic and Diagnostic Implications of Blood Coq10 Levels. In: Biomedical and Clinical Aspects of Coenzyme Q, Folkers, K., T. Yamagami and G.P. Littarru (Eds.). Elsevier, Amsterdam, ISBN: 0444811524, pp: 167-178.
38. Lockwood, K., S. Moesgaard and K. Folkers, 1994a. Partial and complete regression of breast cancer in patients in relation to dosage of coenzyme Q10. Biochem. Biophys. Res. Commun., 199: 1504-1508. http://www.ncbi.nlm.nih.gov/ pubmed/908519
39. Lockwood, K., S. Moesgaard, T. Hanioka and K. Folkers, 1994b. Apparent partial remission of breast cancer in 'high risk' patients supplemented with nutritional antioxidants, essential fatty acids and coenzyme Q10. Mol. Aspects Med., 15: 231-240. http://www.ncbi.nlm.nih.gov/pubmed/7752835
40. Lockwood, K., S. Moesgaard, T. Yamamoto and K. Folkers, 1995. Progress on therapy of breast cancer with vitamin Q10 and the regression of metastases. Biochem. Biophys. Res. Commun., 212: 172-177. http://www.ncbi.nlm.nih.gov/ pubmed/7612003
41. Lorgeril, M., S. Renaud, N. Mamelle, P. Salen and J.L. Martin et al., 1994. Mediterranean alphalinolic acid-rich diet in secondary prevention of coronary heart disease. Lancet, 343: 1454-1459. http://www.ncbi.nlm.nih.gov/ pubmed/7911176
42. Mancuso, M., D. Orsucci, L. Volpi, V. Calsolaro and G. Siciliano, 2010. Coenzyme q10 in neuromuscular and neurodegenerative disorders. Curr. Drug. Targets., 11: 111-121. http://www.ncbi.nlm.nih.gov/pubmed/20017723
43. Martnius, R.D., A.W. Linnane and P. Nagley, 1993. Growth of human namalwa cells lacking oxidative phosphorylation can be sustained by redox compounds potassium ferricyanide or coenzyme Q10 putatively acting through the plasma membrane oxidase. Biochem. Mol. Biol. Int., 31: 997-1005. http://www.ncbi.nlm. nih.gov/pubmed/8193603
44. Mellstedt, H., A. Osterborg, M. Nylander, M. Morita and K. Folkers, 1994. A deficiency of coenzyme Q10 (COQ10) in conventional cancer therapy and blood levels of CoQ10 in cancer patients in Sweden. Mol. Aspects Med., 15. http://faculty.washington.edu/ely/coenzq10.html
45. Miceli, N., M.R. Mondello, M.T. Monforte, V. Sdrafkakis and P. Dugo et al., 2007. Hypolipidemic effects of citrus bergamia rissoet Poiteau juice in rats fed a hypercholesterolemic diet. J. Agric. Food Chem., 55: 10671-10677. http://www.ncbi.nlm.nih.gov/pubmed/18038978
46. Modi, P.K, V.S. Akarma, K. Ramesh, R.K. Goyal and P.A. Bhatt, 2006a. Beneficial effects of coenzyme Q10 in streptozotocin-induced type I diabetic rats. Iran. J. Pharmacol. Therap., 5: 61-65. www.bioline.org.br/pdf?pt06010
47. Modi, K., D.D. Santani, R.K. Goyal and P.A. Bhatt, 2006b. Effect of coenzyme Q10 on catalase activity and other antioxidant parameters in streptozotocin-induced diabetic rats. Biol. Trace Elem. Res., 109: 25-34. http://www.ncbi.nlm.nih.gov/pubmed/16388100
48. Mortensen, S.A., 2003. Overview on coenzyme Q10 as adjunctive therapy in chronic heart failure. Rationale, design and end-points of "Q-symbio"- a multinational trial. Biofactors, 18: 79-89. http://www.ncbi.nlm.nih.gov/ pubmed/14695923
49. Nakagami, H., M.K. Osako, Y. Takami, H. Hanyama and M. Mori et al., 2009. Vascular protective effects of ezetimibe in Apo e-deficient mice. Atherosclerosis, 203: 51-58. http://www.ncbi.nlm.nih.gov/pubmed/18603252
50. National Cholesterol Education Program Expert Panel, 2001. Summary of the third report of NCEP expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J. Am. Med. Assoc., 285: 2486-2497. http://www.ncbi.nlm.nih.gov/pubmed/11368702
51. Nayler, W.G., 1980. The Use of Coenzyme Q10 to Protect Ischemic Heart Muscle. In: Biomedical and Clinical Aspects of Coenzyme Q, Yamamura, Y., K. Folkers and Y. Ito (Eds.). Elsevier, Amsterdam, ISBN: 0444415796, pp: 409-425.
52. Pandya, N.D. S. and S. Jain, 2006. Antioxidant activity of ezetimibe in hypercholesterolemic rats. Indian J. Pharmacol., 38: 205-2006. medind.nic.in/ibi/t06/i3/ibit06i3p205.pdf
53. Pappolla, M.A., M.A. Smith, T. Bryant-Thomas, N. Bazan and S. Petanceska et al., 2002. Cholesterol, oxidative stress and Alzheimer's disease: Expanding the horizons of pathogenesis. Free Radic. Biol. Med., 33: 173-181. http://www.ncbi.nlm.nih.gov/pubmed/12106813
54. Park, C.H., E.J. Cho and T. Yokozawa, 2009 Protection against hypercholesterolemia by corni fructus extract and its related protective mechanism. J. Med. Food, 12: 973-981. http://www.ncbi.nlm.nih.gov/pubmed/ 19857059
55. Pihko, H., U. Saarinen and A. Paetau, 1989. Wernicke encephalopathy-a preventable cause of death: Report of 2 children with malignant disease. Pediatr. Neurol., 5: 237-242. http://www.ncbi.nlm.nih.gov/pubmed/2679584
56. Prasad, K., 2005. Hypocholesterolemic and antiatherosclerotic effect of flax lignan complex isolated from flax seed. Atherosclerosis, 179: 269-275.PMID: 15777541
57. Pyo, Y.H. and K.S. Seong, 2009. Hypolipidemic effects of Monascus-fermented soybean extracts in rats fed a high-fat and -cholesterol diet. J. Agric. Food Chem., 57: 8617-8622. PMID: 19697921
58. Rachh, P.R., M.R. Rachh, D.C. Ghadiya, K.P. Modi and N.M. Modi et al., 2010. Antihyperlipidemic activity of Gymenma sylvestre R. Br. Leaf extract on rats fed with high cholesterol diet. Int. J. Pharmacol., 6: in print. docsdrive.com/pdfs/ansinet/ijp/0000/16059-16059.pdf
59. Ramirez-Tortosa, M.C., M.D. Mesa, M.C. Aguilera, J.L. Quiles and L. Baro et al., 1999. Oral administration of a turmeric extract inhibits LDL oxidation and has hypocholesterolemic effect in rabbits with experimental atherosclerosis. Atherosclerosis, 147: 371-78. PMID: 10559523
60. Ramirez-Tortosa, M.C., S. Granados, C.L. Ramirez-Tortosa, J.J. Ochoa and P. Camacho et al., 2008. Oxidative stress status in liver mitochondria and lymphocyte DNA damage of atherosclerotic rabbits supplemented with water soluble coenzyme Q10. Biofactors, 32: 253-273. PMID: 19096124
61. Rosenfeldt, F., D. Hilton, S. Pepe and H. Krum, 2003. Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure. Biofactors, 18: 91-100. PMID: 14695924
62. Ross, R., 1999. Atherosclerosis-An inflammatory disease. N. Eng. J. Med., 340: 115-126. PMID: 9887164
63. Shimoda, H., J. Tanaka, Y. Takahara, K. Takemoto and S.J. Shan et al., 2009. The hypocholesterolemic effects of cistanche tubulosa extract, A Chinese traditional crude medicine, in mice. Am. J. Chin. Med., 37: 1125-1138. PMID: 19938221
64. Singh, R.B. and M.A. Niaz, 1999. Serum concentration of lipoprotein (a) decreases on treatment with hydrosoluble coenzyme Q10 in patients with coronary artery disease: Discovery of a new role. Int. J. Cardiol., 68: 23-29. PMID: 10077397
65. Singh, R.B., S.N. Shinde, R.K. Chopra, M.A. Naiz and A.S. Thakur et al., 2000. Effect of coenzyme Q10 on experimental atherosclerosis and chemical composition and quality of atheroma in rabbits. Atherosclerosis, 148: 275-282. PMID: 10657562
66. Son, I.S., J.H. Kim, H.Y. Sohn, J.S. Kim and C.S. Kwon, 2007. Antioxidative and hypolipidemic effects of diosgenin, a steroidal saponin of yam (Dioscorea spp.) on high-cholesterol fed rats. Biosci. Biotechnol. Biochem., 71: 3063-3071. PMID: 18071250
67. Spindler, M., M.F. Beal and C. Henchcliffe, 2009. Coenzyme Q10 effects in neurodegenerative disease. Neuropsychiatr Dis. Treat., 5: 597-610. PMID: 19966907
68. Steinberg, D., S. Parthasarathy, T.E. Carew, J.C. Khoo and J.L. Witztum, 1989. Beyond cholesterol modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med., 320: 915-924. PMID: 2648148
69. Sugiyama, S., M. Kitazawa, T. Ozawa, K. Suzuki and Y. Izawa, 1980. Anti-oxidative effect of coenzyme Q10. Experientia, 36: 1002-1003. PMID: 7439318
70. Sun, I.L., E.E. Sun, F.L. Crane, V.J. Morre, A. Lindgren and H. Low, 1992. Requirement for coenzyme Q in plasma membrane electron transport. Proc. Nat. Acad. Sci. U.S.A., 89: 11126-11130. PMID: 1454789
71. Tran, M.T., T.M Mitchell., D.T. Kennedy and J.T. Giles, 2001. Role of coenzyme Q10 in chronic heart failure, angina and hypertension. Pharmacotherapy, 21: 797-806. PMID: 11444576
72. Vijaimohan, K., M. Jainu, K.E. Sabitha, S. Subramaniyam and C. Anandhan et al., 2006. Beneficial effects of alpha linolenic acid rich flax seed oil on growth performance and hepatic cholesterol metabolism in high fat diet fed rat. Life Sci., 79: 448-454. PMID: 16490217
73. Wald, N.J. and M.R. Law, 1995. Serum cholesterol and ischaemic heart disease. Atherosclerosis, 118: S1-S5. PMID: 8821459
74. Yao, R.X., C.Y.H. Liao, Y. Chen, J.J. Xie and X. Yu et al., 2008. Molecular mechanisms of felodipine suppressing atherosclerosis in high-cholesterol-diet apolipoprotein E-knockout mice. J. Cardiovasc. Pharmacol., 51: 188-195. PMID: 18287887
75. Zhou, S., Y. Zhang, A. Davie, S. Marshall-Gradisnik and H. Hu et al., 2005. Muscle and plasma coenzyme Q10 concentration, aerobic power and exercise economy of healthy men in response to four weeks of supplementation. J. Sports Med. Phys. Fitness, 45: 337-346. PMID: 16230985
76. Zulkhairi, A., Z. Zaiton, M. Jamaluddin, F. Sharida and T.H. Mohd et al., 2008. Alpha lipoic acid possess dual antioxidant and lipid lowering properties in atherosclerotic-induced New Zealand White rabbit. Biomed. Pharmacother., 62: 716-722. PMID: 18538528